These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12841134)

  • 1. [Morphological criteria of treatment efficiency in patients with acute pyoinflammatory diseases of the maxillofacial area].
    Durnovo EA; Artifeksova AA; Orlinskaia NIu; Furman IV
    Stomatologiia (Mosk); 2003; 82(3):12-4. PubMed ID: 12841134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of nitatsid and gipozol'-N in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Tarasenko SV; Aleksashina IP; Agapov VS; Trukhina GM; Liapunov NA
    Stomatologiia (Mosk); 2000; 79(2):17-9. PubMed ID: 10812984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative evaluation of the efficacy of endolymphatically administered antibiotics in the combined treatment of phlegmons of the maxillofacial area].
    Tereshchenko AE; Kuznetsov EA
    Stomatologiia (Mosk); 1996; Spec No():82-3. PubMed ID: 9281184
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical course of pyoinflammatory diseases of the maxillofacial area similar to anthrax manifestations].
    Ter-Asaturov GP; Shamanaev SV; Grebennikova IP
    Stomatologiia (Mosk); 2003; 82(4):69-71. PubMed ID: 12931428
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug stimulation of the healing of suppurative wounds of the maxillofacial area].
    Agapov VS; Liapunov NA; Trukhina GM; Tarasenko SV
    Stomatologiia (Mosk); 1996; Spec No():41-2. PubMed ID: 9281127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Supersorbicid in comprehensive treatment of acute pyoinflammatory processes in maxillofacial region].
    Eshbadalov KhIu
    Stomatologiia (Mosk); 2005; 84(2):36-7. PubMed ID: 15798751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Arion VIa; Sysoeva OP; Krugliakova EP
    Stomatologiia (Mosk); 1996; 75(2):31-3. PubMed ID: 8754536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Our experience with the treatment and prevention of acute suppurative complications in different surgical interventions in the oral cavity].
    Tikhonov ES; Smirnov IV; Kretsu II; Novikov MN
    Stomatologiia (Mosk); 1996; Spec No():83-4. PubMed ID: 9281185
    [No Abstract]   [Full Text] [Related]  

  • 9. [Peculiarities of endotracheal anesthesia in patients with severe odontogenic phlegmon].
    Shalabaev OD; Shalabaeva KZ
    Stomatologiia (Mosk); 2012; 91(1):46-7. PubMed ID: 22678608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The optimization of the regeneration of a suppurative wound in the maxillofacial area by using lymphogenic therapy].
    Shumskiĭ AV; Pozdniĭ AIu; Morozov PV
    Voen Med Zh; 1999 May; 320(5):28-33. PubMed ID: 10401246
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of ozonized solutions in the combined treatment of odontogenic putrefactive-necrotic phlegmons of the maxillofacial area and neck].
    Lazutikov OV; Lunev BV
    Stomatologiia (Mosk); 1996; Spec No():64-5. PubMed ID: 9281158
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physical factors in the combined treatment of acute suppurative-inflammatory processes of the maxillofacial area].
    Nikitin AA; Gerasimenko MIu; Kosiakov MN; Nevrov AA
    Stomatologiia (Mosk); 1996; Spec No():69-70. PubMed ID: 9281166
    [No Abstract]   [Full Text] [Related]  

  • 13. [The atypical and chronic course of suppurative inflammatory diseases of the maxillofacial area and the diagnostic and treatment methods].
    Fomichev EV; Romanenko NV
    Stomatologiia (Mosk); 1996; Spec No():85-6. PubMed ID: 9281188
    [No Abstract]   [Full Text] [Related]  

  • 14. [The characteristics of managing and treating patients with suppurative-inflammatory processes of the maxillofacial area and diabetes mellitus].
    Ivasenko PI; Ivankovich VA; Zagainaia NG; Stepanova OP; Tarasiuk SG
    Stomatologiia (Mosk); 1996; Spec No():58-9. PubMed ID: 9281150
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of lasers and a plasma surgical unit in the combined treatment of patients with inflammatory diseases of the maxillofacial area].
    Shargorodskiĭ AG; Zabelin AS; Poliakova VV; Pasevich IA; Kuz'mina EV
    Stomatologiia (Mosk); 1996; Spec No():40-1. PubMed ID: 9281126
    [No Abstract]   [Full Text] [Related]  

  • 16. [The local treatment of suppurative wounds of the maxillofacial area].
    Starodubtsev VS; Biberman IaM
    Stomatologiia (Mosk); 1996; Spec No():78-9. PubMed ID: 9281179
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leukinferon-induced changes in cytochemical parameters of the wound exudate neutrophilic granulocyte nucleus and cytoplasm in patients with maxillofacial phlegmons].
    Tsymbalov OV; Beliaev DL; Evglevskiĭ AA; Demchenko VA
    Stomatologiia (Mosk); 2004; 83(4):42-5. PubMed ID: 15340304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do anti-inflammatory drugs worsen odontogenic cervico-facial cellulitis?
    Nicot R; Hippy C; Hochart C; Wiss A; Brygo A; Gautier S; Caron J; Ferri J; Raoul G
    Rev Stomatol Chir Maxillofac Chir Orale; 2014 Nov; 115(5):e31-6. PubMed ID: 25212878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mediastinitis--a severe complication of acute odontogenic inflammatory processes of the maxillofacial area].
    Nikitin AA; Kosiakov MN; Nevrov AN; Rubtsov IA; Lapshin VP; Zhdanov EV
    Stomatologiia (Mosk); 1996; Spec No():70-1. PubMed ID: 9281168
    [No Abstract]   [Full Text] [Related]  

  • 20. [The efficacy of using ozone in the combined treatment of disseminated odontogenic phlegmons of the maxillofacial area].
    Kiniapina ID; Durnovo EA
    Stomatologiia (Mosk); 1996; Spec No():60-1. PubMed ID: 9281153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.